ViroGates announces a delay in the development and launch of its suPARnostic® POC+ product

2021-01-07

ViroGates A/S, a medical technology company developing blood tests for better triaging in hospitals to improve patient care and reduce healthcare costs, announces that the development of the company’s new point-of-care product, suPARnostic® POC+,will be delayed to the second half of 2021.

Läs hela meddelandet på ViroGates hemsida.

Läs mer..



Västra Hamnen Corporate Finance AB | Jungmansgatan 12 | 211 11 Malmö | 040-200 250 | info@vhcorp.se